Piciclib 75MG Capsule (21’s) is a medication that contains the active ingredient Palbociclib, which is primarily used in the treatment of certain types of breast cancer. This drug is specifically indicated for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer, often in combination with aromatase inhibitors or other hormonal therapies. Each capsule contains 75 mg of Palbociclib, which works by inhibiting specific proteins known as cyclin-dependent kinases (CDKs), particularly CDK4 and CDK6. By blocking these proteins, Piciclib helps to slow down or stop the growth of cancer cells, thereby improving patient outcomes. The formulation is designed for oral administration, making it convenient for patients to incorporate into their daily routines. Overall, Piciclib 75MG Capsule plays a crucial role in the management of advanced breast cancer, offering hope and improved quality of life for many patients.

Piclib 75MG Capsule (21’s) is a prescription medication that contains Palbociclib, a targeted therapy used primarily in the treatment of certain types of breast cancer. Specifically, it is indicated for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer, often in combination with aromatase inhibitors or other hormonal therapies. Each capsule contains 75 mg of Palbociclib, which works by inhibiting specific proteins known as cyclin-dependent kinases (CDKs), particularly CDK4 and CDK6. This inhibition disrupts the cancer cell cycle, slowing down or stopping the growth of cancer cells. Piclib is typically prescribed for patients whose cancer has progressed after initial treatment, making it a crucial option in the management of advanced breast cancer. The drug is taken orally, and its effectiveness is enhanced when used in conjunction with other cancer therapies, providing a comprehensive approach to treatment.